2012-09-11 08:29:55 - ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report –China Interventional Cardiovascular Device Industry Report, 2011-2012
As the increase in the morbidity of cardiovascular and cerebrovascular diseases, the rise in per capita income and the expansion of medical insurance payment proportion, the demand for interventional cardiovascular devices has been effectively released in China in recent years. In 2011, the interventional cardiovascular device market scale (by the selling price of hospital terminals) in China approximated RMB11.69 billion, of which, the market size of cardiovascular stents hit RMB8.17 billion and that of the supporting devices for operation approximated RMB3.52 billion. In 2007-2011, the cardiovascular stent market scale of China presented a CAGR of 21.0%.
In recent years, Chinese interventional cardiovascular device enterprises have made much progress in R&D capability, scale of capital and brand influence, seizing more and
more market share thanks to their advantages in price and channel. And the foreign counterparts are going into overdrive to tap into Chinese market by establishing plants there or by joint venture and M&A. At present, Chinese industrial players far outstrip its foreign peers concerning the market occupancy of coronary stents, while the foreign businesses still dominate the supporting device market.? ?
Having laid a sound foundation and formed a competitive pattern, the interventional cardiovascular device industry of China characterizes quite high entry barriers. Thus, disorderly competition will pose little risk to the businesses, ensuring their gross margin at a higher level. In 2007-2011, the gross margins of leading players in interventional cardiovascular device industry including MicroPort, Lepu Medical and weigaogroup were all kept above 75.0%.? ?
The report highlights the followings :
Market scale, import & export, profit level, competition pattern, etc of Chinese interventional cardiovascular device industry;
Regulatory policy, industrial policy, entry barrier, influence from upstream and downstream sectors;
Market segments such as coronary stent, balloon catheter, conduit, etc.
Production, operation, business, operation in China of Top 5 foreign interventional cardiovascular device manufacturers;
Production, operation, investment, M&A and businesses of leading Chinese interventional cardiovascular device manufacturers.
For details of this report please visit： www.researchinchina.com/Htmls/Report/2012/6512.html